It is a pharma private limited company based in Valsad, Gujarat, India, established in 1983.
1983 | Valsad, Gujarat, India | ActiveNew Generic Drug House Private Limited, a active private limited company, was established on 05 May 1983 in Valsad, Gujarat, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230GJ1983PTC006156. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹9.66 M.
It upholds a active non-compliant status. Its leadership includes Jasumati Pramodrai Vyas (Additional Director), Dhirajlal Mepabhai Patel (Director). Past directors included Mahesh Labhubhai Trivedi, Dhirajlal Mepabhai Patel, Atul Pramodrai Vyas. It holds no open charges and ₹6.85 Cr settled loans. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at 211 & 213, Gidc Industrial Estate, Village- Sarigam, Valsad, Gujarat, 396155.
U24230GJ1983PTC006156
006156
05 May 1983
₹2.00 Cr
₹9.66 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into New Generic Drug House Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jasumati Pramodrai Vyas | Additional Director | 26 Feb 2019 | Current |
| Dhirajlal Mepabhai Patel | Director | 09 Jun 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Oct 2010 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2010 | Past |
| Pramod Abcsdd | Managing Director | 26 Feb 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
New Generic Drug House Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 50% decrease. The company also saw a substantial improvement in profitability, with a 97.04% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, New Generic Drug House had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹68,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2004 | Jankalyan Sehkari Bank Ltd | ₹3.50 M | Satisfied |
| 23 Jul 2003 | Jankalyan Sehkari Bank Ltd | ₹7.50 M | Satisfied |
| 16 Jan 2002 | Jankalyan Sehkari Bank Ltd | ₹2.00 Cr | Satisfied |
| 28 Jan 2000 | Jankalyan Sehkari Bank Ltd | ₹1.50 Cr | Satisfied |
| 01 Sep 1998 | Jankalyan Sahakari Bank Limited | ₹2.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with New Generic Drug House, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of New Generic Drug House, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New Generic Drug House's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Jasumati Pramodrai Vyas was appointed as a Additional Director was appointed as a Additional Director on 26 Feb 2019 & has been associated with this company since 6 years 9 months . was recorded as a recent event.
Progress on New Generic Drug House Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was documented.
Progress on New Generic Drug House Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Ahmedabad. was documented.
Progress on A charge registered on 29 Mar 2004 via Charge ID 90110714 with Jankalyan Sehkari Bank Ltd was fully satisfied on 09 Sep 2010. was documented.
A charge registered on 23 Jul 2003 via Charge ID 90110594 with Jankalyan Sehkari Bank Ltd was fully satisfied on 09 Sep 2010. was recorded as a recent event.
The activity A charge registered on 16 Jan 2002 via Charge ID 90110393 with Jankalyan Sehkari Bank Ltd was fully satisfied on 09 Sep 2010. was completed.
The CIN of New Generic Drug House Private Limited is U24230GJ1983PTC006156.
New Generic Drug House Private Limited is headquartered at 211 & 213, Gidc Industrial Estate, Village- Sarigam, Valsad, Gujarat, 396155.
New Generic Drug House Private Limited was incorporated on 05 May 1983.
The current directors of New Generic Drug House Private Limited are
The primary industry of New Generic Drug House Private Limited is Pharma.
New Generic Drug House Private Limited is unlisted.
The authorized capital of New Generic Drug House Private Limited is ₹2.00 Cr, and the paid-up capital is ₹9.66 M.
The compliance status of New Generic Drug House Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX